News
April 24, 2023 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved the newest addition to its feline portfolio — NexGard ® COMBO ...
Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) has approved the newest innovation from the trusted NexGard Brand of Products — NexGard PLUS (afoxolaner, moxidectin and ...
With advancements in veterinary medicine, pet owners now have access to effective solutions, such as Boehringer Ingelheim's NexGard® COMBO for cats. This groundbreaking, easy-to-apply formula provides ...
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continues to advance its pipeline in both Human Pharma and Animal Health expanding ...
The NexGard ® COMBO formulation is the latest example of Boehringer Ingelheim building on its history of leadership in animal health to provide advanced, preventive animal healthcare and develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results